Company overview
Watchmaker Genomics develops high-performance enzymes and streamlined library preparation kits for next-generation sequencing (NGS) in genomics, transcriptomics, epigenomics, and molecular diagnostics. Their precision-engineered solutions, including RNA and DNA library preps, reverse transcriptases, and PCR-free whole genome sequencing workflows, enhance efficiency, sensitivity, and reproducibility for challenging samples in pharma R&D and clinical applications. They offer custom formulations and partnerships to support precision medicine and large-scale studies.
Watchmaker Genomics is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include ngs library prep, enzyme engineering, whole genome sequencing, rna sequencing kits, molecular diagnostics.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Watchmaker Genomics include Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://watchmakergenomics.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- ngs library prep, enzyme engineering, whole genome sequencing, rna sequencing kits, molecular diagnostics
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What NGS library prep solutions does Watchmaker Genomics offer?
- Streamlined DNA and RNA library prep kits for whole genome sequencing (PCR-free), transcriptomics, and epigenomics, compatible with platforms like Singular Genomics G4, delivering high efficiency from low inputs.
- What are the key capabilities of their enzyme engineering platform?
- Computationally driven directed evolution and rational design produce thermostable, inhibitor-tolerant enzymes like advanced reverse transcriptases for RNA analysis, CRISPR-Cas9 for library normalization, and qPCR kits for molecular diagnostics.
- Do they provide custom solutions for pharmaceutical and diagnostic applications?
- Yes, custom formulations, configurations, labeling, and kitting for NGS reagents and enzymes tailored to life science, clinical, and pharma needs, including partnerships like with Promega for reverse transcriptase.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
